Wendy Lou Jones

Jones is CEO of Royal Knight, Inc., promoting research into kidney cell regeneration. She has written and supervised clinical studies, worked in Canad in oncology, at Mayo Clinic in arthritis research, and in Austria's largest pharmaceutical.